TumorGen is Fighting the Root Cause of Cancer
Dr. Jeff Allen
President, CEO and Founder talks about the Vision of TumorGen
While tremendous strides continue developing new targeted therapies to fight the primary tumor, focus on the mechanisms of cancer metastasis remains challenging. New evidence is demonstrating that tumor metastasis is strongly driven by circulating cancer cell clusters, that differ from the primary tumor in many ways. The CSC ™ System is capable of capturing and preserving circulating cancer cell clusters, thus providing a window into the different mechanisms of cancer metastasis.
Our system opens up new therapeutic target spaces and enables candidate drug validation in pre-clinical ex-vivo studies, de-risking future clinical trials.